Abstract
Febrile neutropenia is an expected complication during treatment of aggressive hematological malignancies and hematopoietic cell transplantation. We conducted a prospective cohort trial to determine the effects and safety of prophylactic fluoroquinolone administration, and rotation of empiric antibiotics for neutropenic fever in this patient population. From March 2002 through 2004, patients were treated with prophylactic levofloxacin during prolonged neutropenia, and a cycling schedule of empiric antibiotic therapy for neutropenic fever was initiated. The rates of bacteremia, resistance and complications were compared to a retrospective cohort of previously treated patients. The rate of gram-negative bacteremia decreased after the initiation of prophylactic levofloxacin (4.7 vs 1.8 episodes/1000 patient days, P<0.05). Gram-positive bacteremia rates remained unchanged, but more isolates of Enterococcus faecium were resistant to vancomycin after the intervention began. Resistance to the antibiotic agents used in the rotation did not emerge. There was no change in mortality during the intervention period. A prophylactic and cycling antibiotic schedule was successfully implemented on a hematological malignancy and hematopoietic cell transplant unit. gram-negative bacteremia was significantly decreased, without emergence of resistance. Concerns with Gram-positive resistance will require further observation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Schimpff S, Satterlee W, Young VM, Serpick A . Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 1971; 284: 1061–1065.
Depauw BE, Deresinski SC, Feld R, Lane-Allman EF, Donnelly JP . Ceftazidime compared to piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. Ann Intern Med 1994; 120: 834–844.
Biron P, Fuhrmann C, Cure H, Viens P, Lefebvre D, Gress JJ et al. Cefepime versus imipenem–cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. J Antimicrob Chemother 1998; 42: 511–518.
Ramphal R, Gucalp R, Rotstein C, Cimino M, Oblon D . Clinical experience with single agent and combination regimens in management of infection in the febrile neutropenic patient. Am J Med 1996; 100: 83S–89S.
Shlaes DM, Gerding DN, John Jr JF, Craig WA, Bornstein DL, Watanakunakorn C et al. Society for Healthcare Epidemiology of America and Infectious Disease Society of America Joint Committee on the Prevention of Antimicrobial Resistance; guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol 1997; 18: 275–291.
Freeman CD, Nicolau DP, Belliveau PP, Nightingale CH . Once daily dosing of aminoglycosides: review and recommendations for clinical practice. J Antimicrob Chemother 1997; 39: 677–686.
World Health Organization. Collaborating Centre for Drug Statistics Methodology. ATC Index with DDDs. WHO: Oslo, Norway, 2004. Available at: http://www.whocc.no/atcddd.Accessed 24 January 2007.
Trifilio S, Verma A, Mehta J . Antimicrobial prophylaxis in hematopoietic stem cell transplant recipients: heterogeneity of current clinical practice. Bone Marrow Transplant 2004; 33: 735–739.
Cruciani M, Rampazzo R, Malena M, Lazzarini L, Todeschini G, Concia E et al. Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis. Clin Infect Dis 1996; 23: 795–805.
Reuter S, Kern WV, Sigge A, Dohner H, Marre R, von Baum H et al. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancy. Clin Infect Dis 2005; 40: 1087–1093.
Gerding DN . Antimicrobial cycling: lessons learned from the aminoglycoside experience. Infect Control Hosp Epidemiol 2000; 21 (Suppl): S12–S17.
John Jr JF, Rice LB . The microbial genetics of antibiotic cycling. Infect Control Hosp Epidemiol 2000; 21 (Suppl): S22–S31.
Masterson RG . Antibiotic cycling: more than it might seem. J Antimicrob Chemother 2005; 55: 1–5.
Brown EM, Nathwani D . Antibiotic cycling or rotation: a systematic review of the evidence of efficacy. J Antimicrob Chemother 2005; 55: 6–9.
Graffunder EM, Venezia RA . Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 2002; 49: 999–1005.
Lautenbach E, Strom BL, Bilker WB, Baldus Patel J, Edelstein PH . Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis 2001; 33: 1288–1294.
Chavers LS, Moser SA, Funkhouser E, Benjamin Jr WH, Chavers P, Waites KB et al. Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci. Microb Drug Resist 2003; 9 (Suppl 1): S69–S77.
Hayden MK . Insights into the epidemiology and control of infection with vancomycin-resistant enterococci. Clin Infect Dis 2000; 31: 1058–1065.
Cetinkaya Y, Falk P, Mayhall CG . Vancomycin-resistant enterococci. Clin Microbiol Rev 2000; 13: 686–707.
Acknowledgements
This work was supported in part by an unrestricted grant from Elan Pharmaceuticals, Inc. We thank Richard Shields, Pam Bunner, Robin Weisenborn, John Thomas, David Styers, Kim Evans and Renee Sager for their assistance with this project and publication.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Craig, M., Cumpston, A., Hobbs, G. et al. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit. Bone Marrow Transplant 39, 477–482 (2007). https://doi.org/10.1038/sj.bmt.1705591
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705591
Keywords
This article is cited by
-
Modelling and Simulation of the Effect of Targeted Decolonisation on Incidence of Extended-Spectrum Beta-Lactamase-Producing Enterobacterales Bloodstream Infections in Haematological Patients
Infectious Diseases and Therapy (2022)
-
Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases
Infection (2016)
-
Antibiotic rotation strategies to reduce antimicrobial resistance in Gram-negative bacteria in European intensive care units: study protocol for a cluster-randomized crossover controlled trial
Trials (2014)
-
Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance
BMC Infectious Diseases (2013)
-
The role of prophylactic antimicrobials during autologous stem cell transplantation: a single-center experience
European Journal of Clinical Microbiology & Infectious Diseases (2012)